SCHEMBL21375235

SCHEMBL21375235

C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)ncc2N2CCOCC2)c1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 11/20 0.80
JAK3 P52333 6/20 0.80
JAK2 O60674 3/20 0.80
BLK P51451 2/20 0.80
BMX P51813 2/20 0.80
BTK Q06187 8/20 0.70
CD69 Q07108 1/20 0.70
KCNH2 Q12809 2/20 0.68
ABCB11 O95342 1/20 0.68
ESR1 P03372 1/20 0.68
CHRM2 P08172 1/20 0.68
HTR1A P08908 1/20 0.68
ADRA2A P08913 1/20 0.68
ADORA3 P0DMS8 1/20 0.68
CHRM1 P11229 1/20 0.68
DRD1 P21728 1/20 0.68
TBXA2R P21731 1/20 0.68
SLC6A2 P23975 1/20 0.68
PDE4A P27815 1/20 0.68
ADRA1A P35348 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21375548 0.89 EGFR (0.64) EGFRJAK3JAK2BLKBMX
SCHEMBL30854720 0.89 EGFR (1.00) EGFRJAK3JAK2BLKBMX
SCHEMBL93510 0.89 EGFR (1.00) EGFRJAK3JAK2BLKBMX
SCHEMBL29351880 0.89 EGFR (1.00) EGFRJAK3JAK2BLKBMX
SCHEMBL10127821 0.88 EGFR (0.82) EGFRJAK3JAK2BLKBMX
SCHEMBL16372156 0.87 EGFR (0.81) EGFRJAK3JAK2BLKBMX
SCHEMBL30672758 0.87 EGFR (0.81) EGFRJAK3JAK2BLKBMX
SCHEMBL21358334 0.87 BTK (0.75) EGFRJAK3JAK2BLKBMX
SCHEMBL21358184 0.87 EGFR (0.65) EGFRJAK3JAK2BLKBMX
Trifluoroacetic Acid SCHEMBL21358543 0.86 EGFR (0.61) EGFRJAK3JAK2BLKBMX

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019177374-A1 2, 4, 5-SUBSTITUTED PYRIMIDINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS EFFECTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER OR INFLAMMATORY DISEASE 포로노이바이오 주식회사 2019-09-19 WO disclosed